Suraksha Diagnostic Limited has informed the Exchange regarding Change in Auditors of the company.
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suraksha Diagnostic's board met on 28 May 2025 and approved its audited standalone and consolidated financial results for Q4 and FY ended 31 March 2025, along with an unmodified opinion declaration signed by the CEO and CFO. The board also issued the notice for the 20th Annual General Meeting scheduled for 5 September 2025. On the auditor front, it appointed M/s Pramod Agarwal & Co. as the new Secretarial Auditor for five years (FY26 to FY30), subject to shareholder approval, and re-appointed M/s Bihani Rashmi & Co. as Internal Auditor and M/s S Chhaparia & Associates as Cost Auditor for FY 2025-26. The statutory auditor was not changed; their report was tabled on the FY25 results.
This is routine annual governance and compliance housekeeping. The new secretarial auditor appointment for a 5-year term and the continuation of the existing internal and cost auditors suggest stability. No material impact expected on the stock price from this filing.